A1AT Investors appears to be related to investments in Alpha-1 Antitrypsin Deficiency research and development. The links provided suggest a focus on biotechnology and pharmaceutical advancements in this area, possibly through organizations like the Alpha-1 Foundation.
Focus Areas
Notable Investments
